Real-world treatment patterns before and after receiving PD-L1 test results in patients (pts) with advanced non-small cell lung cancer (aNSCLC)

被引：0
|
作者：
Antonia, S. J. [1 ]
Wu, N. [2 ]
Ge, W. [2 ]
Pouliot, J-F. [2 ]
Dietz, H. [1 ]
Jalbert, J. [2 ]
Quek, R. G. [2 ]
Harnett, J. [2 ]
机构：
[1] Duke Univ, Ctr Canc Immunotherapy, Sch Med, Durham, NC USA
[2] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
103P
引用
收藏
页码：S1419 / S1420
页数：2
相关论文
共 50 条
  • [21] Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC).
    Ma, Meng
    Zhou, Xiang
    Goldsweig, Howard
    Hahner, Nicholas
    Han, Dianwei
    Dietz, Matthew
    Jones, Scott
    Mullaney, Tommy
    Redfern, Arielle
    Jappe, Whitney
    Liu, Zongzhi
    Yadav, Kamlesh
    Zimmerman, Michelle
    Prentice, Tony
    Pan, Qi
    Hirsch, Fred R.
    Oh, William K.
    Schadt, Eric E.
    Li, Dan
    Chen, Rong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): A real-world analysis
    Pretelli, G.
    Pavan, A.
    Dal Maso, A.
    Resi, M. V.
    Mulargiu, C.
    Ferro, A.
    Benetti, B.
    Lorenzi, M.
    Marinato, G. M.
    Frega, S.
    Pasello, G.
    Conte, P. F.
    Guarneri, V.
    Bonanno, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S51 - S51
  • [23] Real-world economic burden of rapid disease progression (RDP) in patients (pts) with advanced/metastatic non-small cell lung cancer (aNSCLC).
    Byfield, Stacey DaCosta
    Molife, Cliff
    Batus, Marta
    Winfree, Katherine B.
    White, John C.
    Cui, Zhanglin Lin
    Lal, Lincy S.
    Stefaniak, Victoria Jennifer
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective
    Prabhakaran, S.
    Russell, P. A.
    Farrall, A. L.
    Asadi, K.
    Barrett, W.
    Cooper, C.
    Cooper, W.
    Duhig, E. E.
    Egan, M.
    Fox, S.
    Godbolt, D.
    Gupta, S.
    Cotton, S.
    Leslie, C.
    Leong, T.
    Moffat, D.
    Qiu, M.
    Sivasubramaniam, V.
    Snell, C.
    Skerman, J.
    Walsh, M.
    Whale, K.
    Klebe, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S479 - S479
  • [25] Real-world treatment patterns and outcomes in patients (pts) with advanced, ALK plus non-small cell lung cancer (NSCLC) in Europe
    Stoyanov, N.
    Anderson, D.
    Combest, A.
    Nguyen, B.
    Ognar, R.
    Reitsma, D.
    Capart, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S860 - S860
  • [26] Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Peng Song
    Jingcheng Zhang
    Congcong Shang
    Li Zhang
    Scientific Reports, 10
  • [27] Real-world treatment patterns and outcomes in US patients (pts) with advanced non-small cell lung cancer (NSCLC) after platinum-based chemotherapy (PBC) and anti-PD-(L)1 treatment
    Velcheti, Vamsidhar
    Moore, Julia
    Wang, Huifen
    Zhu, Xinmei
    Samyshkin, Yevgeniy
    Ward, Thomas
    Christensen, Alena
    Solem, Caitlyn
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC).
    Swaminathan, Akshay
    Stergiopoulos, Stella
    Snider, Jeremy
    Fisher, Virginia
    Castellanos, Emily
    Snow, Tamara
    Cho-Phan, Cheryl
    Comment, Leah
    Cunningham, Rachel
    McCusker, Margaret E.
    CANCER RESEARCH, 2021, 81 (13)
  • [29] Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer
    Ge, Wenzhen
    Wu, Ning
    Quek, Ruben G. W.
    Liu, Jinjie
    Pouliot, Jean-Francois
    Dietz, Hilary
    Jalbert, Jessica J.
    Harnett, James
    Antonia, Scott J.
    ADVANCES IN THERAPY, 2022, 39 (10) : 4645 - 4662
  • [30] Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer
    Wenzhen Ge
    Ning Wu
    Ruben G. W. Quek
    Jinjie Liu
    Jean-Francois Pouliot
    Hilary Dietz
    Jessica J. Jalbert
    James Harnett
    Scott J. Antonia
    Advances in Therapy, 2022, 39 : 4645 - 4662
12345